ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 30 filers reported holding ALLENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $98,000 | +63.3% | 62 | 0.0% | 0.00% | – |
| Q1 2020 | $60,000 | -64.5% | 62 | 0.0% | 0.00% | – |
| Q4 2019 | $169,000 | -96.8% | 62 | -95.4% | 0.00% | – |
| Q3 2019 | $5,354,000 | -3.2% | 1,359 | 0.0% | 0.00% | – |
| Q2 2019 | $5,531,000 | -68.2% | 1,359 | -45.1% | 0.00% | – |
| Q1 2019 | $17,374,000 | +13162.6% | 2,475 | +10212.5% | 0.00% | – |
| Q4 2018 | $131,000 | -93.8% | 24 | -87.9% | 0.00% | – |
| Q3 2018 | $2,127,000 | -27.5% | 198 | -12.0% | 0.00% | – |
| Q2 2018 | $2,932,000 | -71.2% | 225 | -75.7% | 0.00% | – |
| Q1 2018 | $10,194,000 | -2.6% | 925 | -11.1% | 0.00% | – |
| Q4 2017 | $10,462,000 | – | 1,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $2,518,000 | 11.16% |
| AIGH Capital Management LLC | 4,000,000 | $3,608,000 | 0.76% |
| Worth Venture Partners, LLC | 980,200 | $884,000 | 0.40% |
| Altium Capital Management LP | 1,067,886 | $963,000 | 0.25% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $3,005,000 | 0.24% |
| Golden Green, Inc. | 33,000 | $30,000 | 0.02% |
| LEVEL FOUR FINANCIAL, LLC | 40,000 | $36,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 152,731 | $138,000 | 0.01% |
| PFM Health Sciences, LP | 284,285 | $256,000 | 0.01% |
| XTX Topco Ltd | 21,443 | $19,000 | 0.01% |